Detail of "7413-36-7"

CAS Number:
7413-36-7
Name:
Benzenemethanol, a-[[(1-methylethyl)amino]methyl]-4-nitro-
Molecular Structure:
Formula:
C11H16 N2 O3
Molecular Weight:
0
Synonyms:
Benzenemethanol,a-[[(1-methylethyl)amino]methyl]-4-nitro-,(?à)-; Benzyl alcohol, a-[(isopropylamino)methyl]-p-nitro-,(?à)- (8CI); (?à)-1-(p-Nitrophenyl)-2-isopropylaminoethanol;(?à)-INPEA; (?à)-Nifenalol; (?à)-a-[(Isopropylamino)methyl]-p-nitrobenzyl alcohol;1-(4-Nitrophenyl)-2-(isopropylamino)ethanol;1-(p-Nitrophenyl)-1-hydroxy-2-(isopropylamino)ethane;2-(p-Nitrophenyl)-1-isopropylamino-2-ethanol; Benzyl alcohol, a-[(isopropylamino)methyl]-p-nitro-;DL-INPEA; DL-N-Isopropyl-p-nitrophenylethanolamine; Isophenethanol;N-Isopropyl-1-(p-nitrophenyl)ethanolamine; Nifenalol; Racemic Nifenalol; dl-a-[(Isopropylamino)methyl]-p-nitrobenzylalcohol; a-[(Isopropylamino)methyl]-p-nitrobenzylalcohol

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Analysis of some: Analysis of some .Some chemicals with cas registry numbers like 13655-52-2 and 13523-86-9 are also used.beta.-receptor blockers. Auterhoff, H.; Stanke, R. (Pharm. Inst., Univ. Tuebingen, Tuebingen, Ger.). Dtsch. Apoth.-Ztg., 116(43), 1596-7 (German) 1976. CODEN: DAZEA2. DOCUMENT TYPE: Journal CA Section: 64 (Pharmaceutical Analysis) The identification of 7 .beta.-receptor-blocking drugs, comprising 2 arylethanol derivs. (nifenalol (I) [7413-36-7] and butidrine [7433-10-5]) and 5 alkanolamine phenol ethers (oxprenolol [6452-71-7], alprenolol [13655-52-2], propanolol (II) [525-66-6], pindolol [13523-86-9], and toliprolol [2933-94-0]), is described on the basis of phys. properties and their color reactions with vanillin-H2SO4 and Marquis reagent in vitro and on silica gel thin-layer plates. The compds. of the 2nd group could be split with HI or HBr, giving rise to allyl iodide and dibromopropanes, resp., by reaction with the side chain. The HBr reaction is esp. suitable for identification of the phenols, because iodinated side products occur with the use of HI. .

Experimental analysis of anti-hypertensive effects of beta-adrenergic blocking agents: Experimental analysis of anti-hypertensive effects of beta-adrenergic blocking agents. Marmo, E.; Caputi, A. P.; Rossi, F. 23846-71-1 and 5302-36-3 are also occured in this study.; Lampa, E.; Vacca, C.; Brita, G.; Saini, R. K.; Di Nola, R. (1st Fac. Med. Surg., Univ. Naples, Naples, Italy). Agressologie, 17(5), 279-95 (English) 1976. CODEN: AGSOA6. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) Some .beta.-adrenergic blocking agents have been evaluated on DOCA hypertension in rats at the level of the sinus carotid baroreceptors, of ganglia, and of the .alpha.-adrenergic, .beta.-adrenergic, dopaminergic, muscarinic, etc. periphery systems in dogs, rat, and cats, and on the renal secretion of renin [9015-94-5] in rats. Dl-alprenolol [23846-70-0], dl-INPEA [7413-36-7], dl-practolol [23313-50-0], dl-pronethalol [2238-85-9], dl-oxprenolol [22972-98-1], dl-propranolol [13013-17-7], dl-UK 6558 (tolamolol) [27763-37-7], and dl-CGP 2175 [37350-58-6] showed antihypertensive activity with action mainly at the level of the vasomotor centers of the central nervous system, of the baroreceptors, with a redn. in renin output, and an increase in purinergic reactivity. .